Clinical trial diversity craters out to lowest level in 10 years, IQVIA finds

Clinical trial diversity craters out to lowest level in 10 years, IQVIA finds

Source: 
Fierce Biotech
snippet: 

While clinical trial activity was strong in 2022 following a pandemic-induced dip, many trends resumed their pre-COVID trajectory—including plummeting diversity in clinical trials.